M.Tech.(Pharm.):Pharmaceutical Technology(Bulk Drugs)

A special feature of the Institute is the Department of Pharmaceutical Technology which has been created with a view to directly interact with industry. The department has a pilot plant associated with it for pilot-scale processing of bulk drugs and natural products. The department has build up facilities for scale up studies during development of technologies for bulk pharmaceutical chemicals and different dosage forms. The department is actively engaged and can collaborate in projects related to the following.

* Process development for enantiomerically pure drugs
* Chemical processing technology for natural products
* Process for conducting eco-friendly reactions involving phase transfer catalysts, ionic liquids as alternate solvent media
* Process for developing anti-diabetic compounds using novel technologies

Processes for the following APIs are available for licensing and other projects that have been completed:

* Mefloquine HCl, Isosorbide-5-mononitrate, Artemether and Artesunate, S-Naproxen & S-Ibuprofen and Dicyclohexylcarbinol
* Process for recycling levo enriched clopidogrel
* Application of phase transfer methods in various production processes
* Process for making chiral unnatural amino acids
* Process for making Escitalopram from racemic citalopram
* Process for making various chiral phase-transfer catalysts
* Synthetic routes for making various tricyclic dual PPAEa/c agonists having antioxidant properties
* Process for making novel 1,4-Naphthoquinones
* Process for making levobupivacaine
* Process for making 2-ethylhexyl 4-methoxycinnamate in ionic liquids